Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 766 AL 780

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial

Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F.

JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.

APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset

Rabipour S, Rajagopal S, Yu E, Pasvanis S, Lafaille-Magnan ME, Breitner J; PREVENT-AD Research Group; Rajah MN.

J Alzheimers Dis. 2020;76(1):97-119. doi: 10.3233/JAD-191292.

Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological Disorders

Mazza M, Marano G, Traversi G, Sani G, Janiri L.

CNS Neurol Disord Drug Targets. 2020;19(4):243-247. doi: 10.2174/1871527319666200601145653.

The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse

Sohn JH, Lee SH, Kwon YS, Kim JH, Kim Y, Lee JJ.

Medicine (Baltimore). 2020 May 29;99(22):e20240. doi: 10.1097/MD.0000000000020240.

The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial

Park KS, Ganesh AB, Berry NT, Mobley YP, Karper WB, Labban JD, Wahlheim CN, Williams TM, Wideman L, Etnier JL.

BMC Neurol. 2020 Jun 6;20(1):231. doi: 10.1186/s12883-020-01732-1.

Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial

Traini E, Carotenuto A, Fasanaro AM, Amenta F.

J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623.

MRI Segmentation and Classification of Human Brain Using Deep Learning for Diagnosis of Alzheimer's Disease: A Survey

Yamanakkanavar N, Choi JY, Lee B.

Sensors (Basel). 2020 Jun 7;20(11):3243. doi: 10.3390/s20113243.

Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative

Fowler ME, Triebel KL, Cutter GR, Schneider LS, Kennedy RE; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2020;76(2):691-701. doi: 10.3233/JAD-200108.

Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review

Piamonte BLC, Espiritu AI, Anlacan VMM.

J Alzheimers Dis. 2020;76(2):725-732. doi: 10.3233/JAD-200378.

Acceptability and Validity of the EQ-5D in Patients Living With Dementia

Michalowsky B, Xie F, Kohlmann T, Gräske J, Wübbeler M, Thyrian JR, Hoffmann W.

Value Health. 2020 Jun;23(6):760-767. doi: 10.1016/j.jval.2020.01.022. Epub 2020 May 22.

Hubs of long-distance co-alteration characterize brain pathology

Cauda F, Mancuso L, Nani A, Ficco L, Premi E, Manuello J, Liloia D, Gelmini G, Duca S, Costa T.

Hum Brain Mapp. 2020 Oct 1;41(14):3878-3899. doi: 10.1002/hbm.25093. Epub 2020 Jun 20.

The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP)

Takemoto M, Ohta Y, Hishikawa N, Yamashita T, Nomura E, Tsunoda K, Sasaki R, Tadokoro K, Matsumoto N, Omote Y, Abe K.

J Alzheimers Dis. 2020;76(2):769-772. doi: 10.3233/JAD-200247.

Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease

Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, Johnson SC, Yang HS, Johnson K, Aisen P, Resnick SM, Sperling R, De Jager PL, Schneider J, Bennett DA, Schrag M, Vardarajan B, Hohman TJ, Mayeux R; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2020 Oct 1;77(10):1288-1298. doi: 10.1001/jamaneurol.2020.1760.

Brain (18)F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer's disease diagnosis

Kucharczak F, Suau M, Strauss O, Ben Bouallègue F, Mariano-Goulart D.

Ann Nucl Med. 2020 Aug;34(8):565-574. doi: 10.1007/s12149-020-01490-7. Epub 2020 Jun 23.

The Relationship between Social Cognition and Executive Functions in Alzheimer's Disease: A Systematic Review

Dos Santos TTBA, de Carvalho RLS, Nogueira M, Baptista MAT, Kimura N, Lacerda IB, Dourado MCN.

Curr Alzheimer Res. 2020;17(5):487-497. doi: 10.2174/1567205017666200626205154.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias